Article Information
History
- May 28, 2026.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Edouard Lhomme, M.D., Ph.D.,1,
- Aurélie Wiedemann, Ph.D.,2,3,
- Ahidjo Ayouba, Ph.D.,4,
- Safaa Ben-Farhat, M.Eng.,5,6,
- Guillaume Thaurignac, MSc,4,
- Céline Roy, Ph.D,5,6,
- Abdoul Habib Beavogui, M.D.,7,
- Seydou Doumbia, M.D., Ph.D.,8,
- Mark Kieh, M.D., M.S.M.H.C.,9,
- Bailah Leigh, M.D.,10,
- Samba Sow, M.D,11,
- Stephen A Migueles, MD,12,
- Deborah Watson-Jones, M.D., Ph.D,13,
- Yazdan Yazdanpanah, M.D., Ph.D,14,15,
- Rodolphe Thiébaut, M.D., PhD.,1,
- Martine Peeters, Ph.D.,4,
- Laura Richert, M.D.,1,
- Yves Levy, M.D., Ph.D.2,3,† and
- PREVAC study Team*
- 1Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform and U1219 BPH, Inria, Sistm, F-33000 Bordeaux, France
- 2French Institute for Health and Medical Research (INSERM), 75013 Paris, France
- 3Vaccine Research Institute, Univ. Paris Est Créteil, Henri Mondor Hospital, Créteil, France
- 4Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France
- 5Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
- 6Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France
- 7Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea
- 8University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
- 9Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
- 10College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone
- 11Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street Baltimore, MD 21201-1509, USA
- 12National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA or under contract/subcontract to NIAID
- 13London School of Hygiene & Tropical Medicine, London, UK
- 14ANRS Emerging Infectious Diseases, Paris, France
- 15AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, Paris F-75018, France
- ↵†Corresponding author:
Pr Yves Levy, Vaccine Research Institute, Université Paris-Est Créteil, INSERM U955, Bâtiment BRB- 1er étage, 8 rue du Général Sarrail, 94010 Créteil, E-mail address: yves.levy{at}aphp.fr
Drs. Lhomme and Wiedemann and Drs. Richert and Levy contributed equally to this article.
Posted May 28, 2026.
